AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL

Adaptive somatic mutations conferring treatment resistance and accelerated disease progression is still a major problem in cancer therapy. Additionally in CLL, patients receiving novel, efficient drugs frequently become treatment refractory and eventually relapse. Activation-induced deaminase (AID)...

Full description

Bibliographic Details
Main Authors: Maria Schubert, Franz Josef Gassner, Michael Huemer, Jan Philip Höpner, Ekaterina Akimova, Markus Steiner, Alexander Egle, Richard Greil, Nadja Zaborsky, Roland Geisberger
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/11/2619

Similar Items